Sergei Afanasev

Sergei Afanasev

Active Director Director DIN 09595283
DIN 09595283 First appointment May 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Sergei Afanasev

Data last updated:

Sergei Afanasev is a Director at Cryotech Pharma Private Limited (since 2022). The company operates in Pharma. Cryotech Pharma Private Limited reported revenue of ₹4.7 Lakh (FY 2023).

DIN 09595283
Primary Designation Director
Industry Pharma
First Appointment 05 May 2022
Oldest Company Age 6 yrs
Largest company Cryotech Pharma Private Limited · ₹4.7 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cryotech Pharma Private Limited U24299KL2020PTC063179
Director05 May 20222020₹4.7 Lakh (FY 2023)Active

Directorship timeline

Open interactive timeline →
Cryotech Pharma Private Limited
Premium access

Shareholding and investment profile for Sergei Afanasev

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sergei Afanasev

Sergei Afanasev currently holds 1 directorship: Cryotech Pharma Private Limited (Director, since 05 May 2022, revenue ₹4.7 Lakh (FY 2023)).

Sergei Afanasev was first appointed on 05 May 2022 as Director at Cryotech Pharma Private Limited.

The current boards of Sergei Afanasev's companies include Jaya Prakash Nair (Cryotech Pharma Private Limited), Lalu Joseph (Cryotech Pharma Private Limited), Reghunathan Pillai Dasappan Pillai (Cryotech Pharma Private Limited), Salim Shahul Hameed (Cryotech Pharma Private Limited), Samras Mayimi (Cryotech Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available